LayerX Security’s Post

Proud to share a recent Gartner Peer Insights review where a CISO from the Healthcare and Biotech industry highlighted why they chose LayerX Security as their trusted partner: "Ease of implementation, provides a long list of features we were looking into in order to strengthen our overall security posture." When CISOs appreciate not just our technology but also our commitment to delivering a seamless experience, it reinforces why we do what we do. It’s not just about the features—it’s about empowering teams to feel secure, agile, and ready for any challenge.

Don't take it from me, listen to what our customers are saying (they're raving). Our best of breed Network Performance Monitoring solutions help our customers: 1. Improve compliance & risk management 2. Create internal/operational efficiencies 3. Improve business process outcomes What really sets us apart though? This review nails it: "The solution performed as advertised and the account and support teams have done an excellent job making sure we get value from the product." Purchasing tools to support IT is a futile effort without excellent support and enablement. We go the extra mile to ensure our customers get the most value possible out of their investments.

Very glad and proud to share another interesting read from our global PwC Health Industry network detailing the FY24 global M&A trends in Health Industries! Short teaser - fierce competition for innovative technologies will accelerate health industries M&A in 2024, as dealmakers navigate headwinds more confidently. Find out more in our global M&A outlook: https://pwc.to/3S6JONI #PwCDeals #ValueCreation

Seeking answers to your most pressing #healthcare business questions? Visit Ipsos’ new healthcare site today: https://lnkd.in/et8sr-6D Explore Ipsos’ world-leading solutions for the healthcare sector, which span market research, evidence generation, access/HEOR, and advisory services. You’ll also find our extensive library of data-led thought leadership, giving you the inside track on trends affecting our sector, prevailing dynamics in key therapy areas, and how to navigate today’s healthcare business challenges. Or connect with an expert to find out how Ipsos can answer your healthcare business question.   #Pharma #Medtech #RealWorldEvidence #MRx

📢 The European Commission announced today the establishment of the #AI Office within the Commission, which will ensure the coherent implementation of the AI Act through various activities, such as: - Collaborating with Member States and the wider expert community through dedicated fora and expert groups, - Working closely with the European Artificial Intelligence Board composed of representatives of Member States. - Coordinating the drawing up of state-of-the-art codes of practice, conducting testing and evaluation of general-purpose AI models, requesting information as well as apply sanctions, when necessary, in cooperation with AI developers, the scientific community and other stakeholders - Preparing guidelines on the AI system definition and on the prohibitions, both due six months after the entry into force of the AI Act. - Ensuring a strategic, coherent and effective European approach on AI at the international level. 🌟 At the Medtech & Pharma Platform Association we also discuss the importance and the implications of #AI for #connectedcombinedproducts. Join our discussion at this year’s Annual Conference! In the session on "Connected combined products and digital health" we will delve into artificial intelligence, data security aspects and #digitalhealth, with speakers from the industry, health authority and patient advocates. Join us in Basel on 3 September 2024 and register here: https://bit.ly/3VfIYkb Theresa Jeary Shayesteh Fürst-Ladani Mike Wallenstein Iain Simpson Ruth Foster #DigitalHealth #ConnectedCombinedProducts #Innovation

The success of a device-enabled digital health solution hinges on a strong value proposition that justifies the costs and drives initiatives forward. While every therapy area can be enhanced by digital technology, it’s crucial to recognize that digital is only one part of the broader go-to-market strategy for pharma. As Stephen Gerrard of ViiV Healthcare highlights, digital health requires new criteria for evaluating value propositions, as traditional criteria may not apply. Learn more about building effective digital health strategies in our latest whitepaper. 👉 https://hubs.li/Q02QKdG30

Want the inside track on #healthcare sector trends? Seeking expert guidance on today’s healthcare business challenges? Need to understand the nuances and dynamics of specific therapy areas…? Visit Ipsos’ new healthcare site today: https://lnkd.in/eRtGVAv4 Access our extensive library of data-led thought leadership, discover our world-leading insight, evidence and advisory solutions, or connect with a sector expert to learn how we can answer your healthcare business question. #Pharma #Medtech #RealWorldEvidence #MRx

If you are mulling over the emergence of the JCA or the inflation reduction act, Anne Heyes, Vice President of RTI Health Solutions, Value & Access, discusses the sweeping developments in HTAs and how the pharma and medtech industries are responding to them. You can learn more about how we support JCAs here https://ow.ly/6RVQ50RzKT8 #HTA #MarketAccess #ISPORAnnual

Are you a life science company looking to to exit into the public markets in 2025? Lets talk! I will be holding 1:1 meetings with companies looking to discuss exist strategies during the JPM 2025 Health Conference. Meetings will be held at Martin Lawrence Galleries. Message me today to set up a strategy session. Don't let the next IPO window pass you by. #IPO #reversemerger #SPAC #lifescience #biotech #pharma #medtech #medicaldevice #transactionadvisory #accountingadvisory #jpm2025